The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Diagnostic utility of (18)f-fluciclovine positron emission tomography (FACBC) in biochemically recurrent (BCR) prostate cancer (PCa) based on prior primary treatment modality for localized disease and the impact of FACBC findings on treatment selection.
 
Marina Nasrin Sharifi
No Relationships to Disclose
 
Petra Lovrec
No Relationships to Disclose
 
Jens C. Eickhoff
Consulting or Advisory Role - Five Prime Therapeutics
Research Funding - Sanofi Pasteur (Inst)
 
Aria Kenarsary
No Relationships to Disclose
 
David Frazier Jarrard
No Relationships to Disclose
 
John Floberg
No Relationships to Disclose
 
Steve Y. Cho
Consulting or Advisory Role - Blue Earth Diagnostics; Focus-X Therapeutics; Progenics
Research Funding - Advanced Accelerator Applications (Inst); GE Healthcare (Inst); Progenics (Inst)
Other Relationship - Radmetrix
 
Christos Kyriakopoulos
Consulting or Advisory Role - Exelixis
Research Funding - Sanofi
 
Hamid Emamekhoo
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Cardinal Health; Exelixis; Exelixis
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - DAVA Pharmaceuticals